Paradigm Biocapital Advisors LP

Q2 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    28

  • Value ($000)

    $2,342,122

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001855655
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
NUVL
NUVL

NUVALENT INC

COM
670703107
$402.06M
17 %

5,269,433

ACLX
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$306.14M
13 %

4,649,016

---

MERUS N V

COM
N5749R100
$225.23M
10 %

4,281,954

RVMD
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$224.17M
10 %

6,093,291

TARS
TARS

TARSUS PHARMACEUTICALS INC

COM
87650L103
$120.56M
5 %

2,976,099

PCVX
PCVX

VAXCYTE INC

COM
92243G108
$109.65M
5 %

3,372,837

BGNE
BGNE

BEONE MEDICINES LTD

SPONSORED ADS
07725L102
$84.19M
4 %

347,787

EWTX
EWTX

EDGEWISE THERAPEUTICS INC

COM
28036F105
$80.53M
3 %

6,142,344

COGT
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$74.33M
3 %

10,352,449

JANX
JANX

JANUX THERAPEUTICS INC

COM
47103J105
$67.46M
3 %

2,920,258

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 28